Clinical trial
ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases
NCT00496379 · Nancy Lin, MD, Other · Terminated
Key facts
| NCT number | NCT00496379 |
|---|---|
| Title | ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases |
| Official title | A Phase 2 Study of ZK219477 (ZK-EPO) in Patients With Breast Cancer and Brain Metastases |
| Lead sponsor | Nancy Lin, MD, Other |
| Collaborators | Brigham and Women's Hospital Bayer Industry Breast Cancer Research Foundation |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, CNS Disease |
| Intervention type | Drug |
| Interventions | ZK219477 |
| Enrollment | 15 |
| Start date | Jul 1, 2007 |
| Primary completion | Oct 1, 2009 |
| Completion | Jan 1, 2012 |
| First posted | Jul 4, 2007 |
| Last update posted | Mar 14, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: